Fred Schwarzer Igm Biosciences, Inc. (IGMS) insider trading activity

Fred Schwarzer is CEO AND PRESIDENT of IGM Biosciences, Inc.. Currently has a direct ownership of 250,124 shares of IGMS, which is worth approximately $1.55 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 3,946 shares (Common Stock) at a price of $11.54 per share, resulting in proceeds of $45,536. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K

0% 3M change

143.2% 12M change

Total Value Held $1.55 Million

Fred Schwarzer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 13 2024	SELL Open market or private sale	$45,536 $11.54 p/Share	3,946 Reduced 1.55%	250,124 Common Stock
Jun 14 2024	SELL Open market or private sale	$31,563 $7.58 p/Share	4,164 Reduced 1.61%	254,070 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	$15,059 $5.02 p/Share	3,000 Added 1.15%	258,234 Common Stock
Mar 26 2024	BUY Grant, award, or other acquisition	-	38,583 Added 13.13%	255,234 Common Stock
Mar 14 2024	SELL Open market or private sale	$42,530 $10.17 p/Share	4,182 Reduced 1.89%	216,651 Common Stock
Mar 13 2024	SELL Open market or private sale	$47,078 $9.88 p/Share	4,765 Reduced 2.11%	220,833 Common Stock
Mar 12 2024	BUY Grant, award, or other acquisition	-	122,750 Added 35.24%	225,598 Common Stock
Dec 13 2023	SELL Open market or private sale	$101,589 $5.78 p/Share	17,576 Reduced 14.6%	102,848 Common Stock
Nov 27 2023	SELL Open market or private sale	$6,765 $5.06 p/Share	1,337 Reduced 1.1%	120,424 Common Stock
May 23 2023	SELL Open market or private sale	$15,938 $12.66 p/Share	1,259 Reduced 1.02%	121,761 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$11,241 $11.71 p/Share	960 Added 0.77%	123,020 Common Stock
Apr 18 2023	BUY Grant, award, or other acquisition	-	34,200 Added 21.89%	122,060 Common Stock
Apr 04 2023	BUY Grant, award, or other acquisition	-	67,500 Added 43.45%	87,860 Common Stock
Dec 16 2022	SELL Open market or private sale	$235,876 $19.07 p/Share	12,369 Reduced 37.79%	20,360 Common Stock
Nov 23 2022	SELL Open market or private sale	$27,273 $21.68 p/Share	1,258 Reduced 3.7%	32,729 Common Stock
May 24 2022	SELL Open market or private sale	$23,290 $17.1 p/Share	1,362 Reduced 3.85%	33,987 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$5,125 $12.38 p/Share	414 Added 1.16%	35,349 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	23,002 Added 39.7%	34,935 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	10,000 Added 45.59%	11,933 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$11,881 $50.99 p/Share	233 Added 10.76%	1,933 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	$14,367 $45.9 p/Share	313 Added 15.55%	1,700 Common Stock
Nov 13 2020	BUY Grant, award, or other acquisition	$13,226 $45.45 p/Share	291 Added 0.15%	198,105 Common Stock

Fred Schwarzer

CEO AND PRESIDENT

Mountain View, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Value

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IGM Biosciences, Inc.

Track Activities on IGMS

Account